^
BIOMARKER:

KRAS G12C + PD-L1 overexpression

i
Other names: KRAS, KRAS proto-oncogene GTPase, KRAS1, KRAS2, NS, NS3, OES, CFC2, RALD, K-Ras, RASK2, KI-RAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, K-Ras 2, C-K-RAS, c-Ki-ras, c-Ki-ras2, Kirsten rat sarcoma viral oncogene homolog, PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule
Entrez ID:
Related biomarkers:
News
Twitter
Trials
KRAS G12C + PD-L1 overexpression
NSCLC
Immunotherapy
Sensitive: C3 – Early Trials
ESMO 2021 - 2 weeks
KRAS G12C + PD-L1 overexpression
NSCLC
pembrolizumab
Sensitive: C4 – Case Studies